News | March 24, 2026
Japan okays new long-acting eye drug
It promises fewer injections for vision loss patients
It promises fewer injections for vision loss patients
Call it a major breakthrough for diagnostic imaging
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
Subscribe To Our Newsletter & Stay Updated
